NATCO PHARMA LTD. - 524816 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of share certificates17-12-2020
NATCO PHARMA LTD. - 524816 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of share certificatesNATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
NATCO launches anti blood clot tablet Rivaroxaban in IndiaNATCO PHARMA LTD. - 524816 - Disclosure Of Related Party Transactions For The Half Year Ended September 30, 2020
Disclosure of Related Party Transactions for the half year ended September 30, 2020Natco Pharma expects agri business to be key growth lever
Natco is focussing on-field farmer activities, demand generation, farmer demonstrations and awareness and handling statutory needs and requirementsHold Natco Pharma; target of Rs 970: ICICI Direct
ICICI Direct recommended hold rating on Natco Pharma with a target price of Rs 970 in its research report dated November 13, 2020.NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor presentation for the quarter ended September 30, 2020Natco Pharma receives USFDA nod for cancer treatment drug
Natco Pharma Ltd has on Friday announced that its marketing partner, Breckenridge Pharmaceutical Inc., has received final approval for its AbbreviatedEarnings Call for Q2FY21 of Natco Pharma
Conference Call with Natco Pharma Management and Analysts on Q2FY21 Performance and Outlook. Listen to the full earnings transcript.NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
NATCO receives Pomalidomide approval for US marketNATCO PHARMA LTD. - 524816 - Board declares Second Interim Dividend
Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 12, 2020, inter alia, has approved the following:- Declaration of second interim dividend of Rs.3 (Rupees three only) per equity share of Rs. 2/- each for the financial year 2020-21.Payment of the said interim dividend will start from December 02, 2020.